Autor: "Figarella-Branger, D." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Deciphering the Action of Neuraminidase in Glioblastoma Models.
Autorzy:: Baeza-Kallee N; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Bergès R; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Hein V; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Cabaret S; ChemoSens Platform, Centre des Sciences du Goût et de l'Alimentation, InstitutAgro, CNRS, INRAE, Université de Bourgogne Franche-Comté, 21000 Dijon, France.
Garcia J; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13005 Marseille, France.
Gros A; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13005 Marseille, France.
Tabouret E; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.; APHM, CHU Timone, Service de Neurooncologie, 13005 Marseille, France.
Tchoghandjian A; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Colin C; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Figarella-Branger D; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 19; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 19.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/metabolism
Brain Neoplasms*/metabolism
Humans ; Neuraminidase/genetics ; Neuraminidase/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Neoplastic Stem Cells/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.
Autorzy:: Gilhodes J; Biostatistics & Health Data Science Unit, Institut Claudius Regaud, Oncopole Claudius Regaud-Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.
Meola A; Department of Radiation Oncology, Institut Claudius Regaud, Oncopole Claudius Regaud-Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.
Cabarrou B; Biostatistics & Health Data Science Unit, Institut Claudius Regaud, Oncopole Claudius Regaud-Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.
Peyraga G; Department of Radiation Oncology, Institut Claudius Regaud, Oncopole Claudius Regaud-Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.
Dehais C; Neuro-Oncology Department, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Sorbonne University, 75006 Paris, France.
Figarella-Branger D; Department of Pathology, Centre Hospitalo-Universitaire Timone, AP-HM, GlioME Team, Institute of Neurophysiopathology, Aix-Marseille University, 13385 Marseille, France.
Ducray F; Neuro-Oncology Department, Hospices Civils de Lyon, Université Lyon 1, CRCL, UMR Inserm 1052_CNRS 5286, 69003 Lyon, France.
Maurage CA; Department of Pathology, Lille University Hospital, 59000 Lille, France.
Loussouarn D; Pathology Department, Hotel-Dieu, CHU Nantes, 44093 Nantes, France.
Uro-Coste E; Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.; Centre de Recherches Contre le Cancer de Toulouse, INSERM U1037, 31100 Toulouse, France.
Cohen-Jonathan Moyal E; Department of Radiation Oncology, Institut Claudius Regaud, Oncopole Claudius Regaud-Institut Universitaire du Cancer Toulouse, 31100 Toulouse, France.; Centre de Recherches Contre le Cancer de Toulouse, INSERM U1037, 31100 Toulouse, France.
Pola Network; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Jun 06; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm.
Autorzy:: Tauziède-Espariat A; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France. .; INSERM, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France. .
Figarella-Branger D; Department of Anatomopathology and Neuropathology, CNRS, INP, Inst Neurophysiopathol, and APHM, La Timone Hospital, Aix-Marseille Univ, 13385, Marseille, France.
Métais A; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.; INSERM, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), INSERM U1037, Toulouse, France.; Université Paul Sabatier, Toulouse III, Toulouse, France.
Maurage CA; Institute of Pathology, Centre de Biologie Pathologie, Lille University Hospital, 59000, Lille, France.
Lhermitte B; Department of Pathology, Strasbourg Hospital, Strasbourg, France.
Aline-Fardin A; Department of Pathology, Fort-de-France Hospital, Fort-de-France, France.
Hasty L; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.
Vasiljevic A; Department of Pathology and Neuropathology, GHE, Hospices Civils de Lyon, Lyon, France.
Chiforeanu D; Department of Pathology, Ponchaillou Hospital, Rennes, France.
Chotard G; Department of Pathology, Pellegrin Hospital, Bordeaux, France.
Adle-Biassette H; Department of Pathology, Lariboisière Hospital, APHP, 75475, Paris, France.
Meurgey A; Department of Biopathology, Léon Bérard Cancer Center, Lyon, France.
Saffroy R; Department of Biochemistry and Oncogenetics, Paul Brousse Hospital, 94804, Villejuif, France.
Guillemot D; Curie Institute Research Center, INSERMU830, Paris-Sciences-Lettres, Paris, France.
Pierron G; Laboratory of Somatic Genetics, Curie Institute Hospital, Paris, France.
Sievers P; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center DKFZ, Heidelberg, Germany.
Varlet P; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 1, rue Cabanis, 75014, Paris, France.; INSERM, UMR 1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.; Pokaż więcej
Corporate Authors:: the RENOCLIP-LOC
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Mar 14; Vol. 11 (1), pp. 43. Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:: Letter
MeSH Terms:: Neuroblastoma*/diagnosis
Humans ; Forkhead Transcription Factors

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion.
Autorzy:: Métais A; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Tauziède-Espariat A; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Garcia J; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Appay R; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.
Meyronet D; Groupe Hospitalier Est, Département de Neuropathologie, Hospices Civils de Lyon, Bron, France.; Claude Bernard University Lyon 1, Lyon, France.; Department of Cancer cell plasticity - INSERM U1052, Cancer Research Center of Lyon, Lyon, France.
Maurage CA; Department of Pathology, Lille University Hospital, Lille, France.
Vandenbos F; Department of Neuropathology, Hôpital Pasteur, Nice, France.
Rigau V; Department of Pathology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Chiforeanu DC; Service d'Anatomie et Cytologie Pathologiques, Pontchaillou University Hospital, Rennes, France.
Pallud J; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.; Department of Neurosurgery, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Senova S; Departments of Neurosurgery and Psychiatry, Assistance Publique-Hôpitaux de Paris (APHP) Groupe Henri-Mondor Albert-Chenevier, Créteil, France.
Saffroy R; Department of Biochemistry and Oncogenetic, APHP, Paul-Brousse Hospital, Villejuif, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Edjlali M; Department of Radiology, APHP, Hôpitaux Raymond-Poincaré and Ambroise Paré, DMU Smart Imaging, U 1179 UVSQ/Paris-Saclay, GH Université Paris-Saclay, Paris, France.; Laboratoire d'imagerie Biomédicale Multimodale (BioMaps), CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Université Paris-Saclay, Orsay, France.
Varlet P; GHU Psychiatrie et Neurosciences, Site Sainte-Anne, service de Neuropathologie, Paris, France.; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Equipe IMA-BRAIN (Imaging Biomarkers for Brain Development and Disorders), Université de Paris, Paris, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France. dominique.figarella-branger@univ-amu.fr.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France. dominique.figarella-branger@univ-amu.fr.; Pokaż więcej
Corporate Authors:: Biopathology RENOCLIP-LOC network
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Jan 16; Vol. 11 (1), pp. 14. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Glioblastoma*/genetics
Glioma*/genetics
Glioma*/pathology
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Ganglioglioma*/genetics
Adult ; Humans ; Child ; Mutation/genetics ; Prognosis ; Epigenesis, Genetic ; DNA ; Isocitrate Dehydrogenase/genetics ; Receptor, Fibroblast Growth Factor, Type 3/genetics ; Microtubule-Associated Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
Autorzy:: Clavreul A; Département de Neurochirurgie, CHU, 49933 Angers, France.; Université d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCINA, F-49000 Angers, France.
Autier L; Département de Neurologie, CHU, 49933 Angers, France.; Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Site Paul Papin, 49055 Angers, France.
Lemée JM; Département de Neurochirurgie, CHU, 49933 Angers, France.; Université d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCINA, F-49000 Angers, France.
Augereau P; Département d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Site Paul Papin, 49055 Angers, France.
Soulard G; Département de Neurochirurgie, CHU, 49933 Angers, France.
Bauchet L; Département de Neurochirurgie, Hôpital Gui de Chauliac, CHU Montpellier, Université de Montpellier, 34295 Montpellier, France.; Institut de Génomique Fonctionnelle, CNRS, INSERM, 34295 Montpellier, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13385 Marseille, France.; Aix-Marseille University, CNRS, INP, Inst. Neurophysiopathol, 13005 Marseille, France.
Menei P; Département de Neurochirurgie, CHU, 49933 Angers, France.; Université d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCINA, F-49000 Angers, France.
Network F; Pokaż więcej
Corporate Authors:: Collaborators of the FGB network
Źródło:: Cancers [Cancers (Basel)] 2022 Nov 09; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH -Mutant Gliomas: A French POLA Network Study.
Autorzy:: Montégut C; Neuro-Oncology Department, University Hospital La Timone, 264 Rue Saint Pierre, 13005 Marseille, France.
Guillamo JS; Nîmes, Centre Hospitalier Universitaire de Nîmes Caremeau, Service de Neurologie, 30000 Nimes, France.
Ducray F; Neuro-Oncology Department, Hospices Civils de Lyon, Université Lyon 1, CRCL, UMR Inserm 1052_CNRS 5286, 69000 Lyon, France.
Dehais C; Service Neurology 2, Mazarin, Assistance Public-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Sorbonne University, 75013 Paris, France.
Cohen-Jonathan Moyal E; Département de Radiothérapie, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059 Toulouse, France.
Desenclos C; Neurosurgery Department, Hôpital Nord, Centre Hospitalo-Universitaire Amiens, 80000 Amiens, France.
Petit A; Neurosurgery Department, Hôpital Jean Minjoz, Centre Hospitalo-Universitaire Besançon, 25000 Besançon, France.
Seizeur R; Neurosurgery Department, Hôpital de la Cavale Blanche, Centre Hospitalo-Universitaire Brest, 29200 Brest, France.
Bekaert L; Neurology Department, Centre Hospitalo-Universitaire de Caen, 14000 Caen, France.
Gaultier C; Neurology Department, Centre Hospitalier Colmar, 68000 Colmar, France.
Motuo Fotso MJ; Neurosurgery Department, Hôpital Nord, Centre Hospitalo-Universitaire Saint-Étienne, 42270 Saint-Priest en Jarez, France.
Blonski M; Service de Neurologie, Hopital Central, Centre Hospitalier Régional Universitaire, 54000 Nancy, France.
Frenel JS; Medical Oncology Department, Institut de Cancérologie de l'Ouest, 11 Boulevard Jacques Monod, 44800 Saint-Herblain, France.
Vauléon E; Medical Oncology Department, Centre Eugene Marquis, INSERMU1242, University of Rennes, 35000 Rennes, France.
Langlois O; Neurosurgery Department, Centre Hospitalo-Universitaire Charles Nicolle, 76000 Rouen, France.
Noel G; Radiotherapy Department, Centre Paul Strauss, 76000 Strasbourg, France.
Carpentier AF; Neurology Department, Hôpital Saint-Louis, 75010 Paris, France.
Di Stefano AL; Service de Neurologie, Hôpital Foch, 92150 Suresnes, France.
Bronnimann C; Hôpital Saint-André Bordeaux, Centre Hospitalier Universitaire, Service d'Oncologie, 33000 Bordeaux, France.
Figarella-Branger D; Service d'Anatomie Pathologique et de Neuropathologie, Centre Hospitalo-Universitaire Timone, APHM, 13005 Marseille, France.; GlioME Team, Institute of Neurophysiopathology, Aix-Marseille University 27 Bd Jean Moulin, 13005 Marseille, France.
Chinot O; Neuro-Oncology Department, University Hospital La Timone, 264 Rue Saint Pierre, 13005 Marseille, France.; GlioME Team, Institute of Neurophysiopathology, Aix-Marseille University 27 Bd Jean Moulin, 13005 Marseille, France.
Tabouret E; Neuro-Oncology Department, University Hospital La Timone, 264 Rue Saint Pierre, 13005 Marseille, France.; GlioME Team, Institute of Neurophysiopathology, Aix-Marseille University 27 Bd Jean Moulin, 13005 Marseille, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Nov 09; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.
Autorzy:: Pagès M; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.; Department of Genetics, Institut Curie, Paris, France.; SIREDO Paediatric Cancer Center, Institut Curie, Paris, France.; INSERM U830, Laboratory of Translational Research in Paediatric Oncology, Institut Curie, Paris, France.; Paris Sciences Lettres Research University, Paris, France.
Debily MA; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Biologie, Univ. Evry, Université Paris-Saclay, Evry, France.
Fina F; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Jones DTW; Pediatric Glioma Research, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Saffroy R; Oncogenetics Department, Assistance Publique-Hôpitaux de Paris, Paul Brousse Hospital, Université Paris-Saclay, Villejuif, France.
Castel D; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Biologie, Univ. Evry, Université Paris-Saclay, Evry, France.
Blauwblomme T; Pediatric Neurosurgery Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; Université de Paris- Cité, Paris, France.
Métais A; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.
Bourgeois M; Pediatric Neurosurgery Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Lechapt-Zalcman E; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.
Tauziède-Espariat A; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.
Andreiuolo F; Department of Neuropathology, Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.; Pathology Division, D'Or Research Institute (IDOR), D'Or Hospitals Network, Rio de Janeiro, Brazil.
Chrétien F; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.; Université de Paris- Cité, Paris, France.
Grill J; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département de Biologie, Univ. Evry, Université Paris-Saclay, Evry, France.; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France.
Boddaert N; Pediatric Radiology Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France.; INSERM ERL UA10, Université de Paris, Paris, France.; Institut Imagine, Université de Paris, UMR 1163, Paris, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Institute of NeuroPhysiopatholy, Aix-Marseille Univ, CNRS, INP, Marseille, France.
Beroukhim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Varlet P; GHU-Paris - Sainte-Anne Hospital, Department of Neuropathology, Paris University, Paris, France.; Pokaż więcej
Źródło:: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Oct; Vol. 48 (6), pp. e12834. Date of Electronic Publication: 2022 Aug 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms*/pathology
Glioma*
Neoplasms, Neuroepithelial*/genetics
Neoplasms, Neuroepithelial*/pathology
Genomics ; Humans ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Stereotactic radiosurgery for post operative brain metastasic surgical cavities: a single institution experience.
Autorzy:: Cantaloube M; Radiotherapy Department, Assistance Publique Des Hôpitaux de Marseille, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Boucekine M; Unity of Research EA3279, Aix-Marseille Université, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Balossier A; Department of Functional and Stereotactic Neurosurgery and Radiosurgery, Timone University Hospital, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Muracciole X; Radiotherapy Department, Assistance Publique Des Hôpitaux de Marseille, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Meyer M; Department of Neurosurgery, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Delsanti C; Department of Functional and Stereotactic Neurosurgery and Radiosurgery, Timone University Hospital, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Carron R; Department of Functional and Stereotactic Neurosurgery and Radiosurgery, Timone University Hospital, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Beltaifa YM; Department of Functional and Stereotactic Neurosurgery and Radiosurgery, Timone University Hospital, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Figarella-Branger D; Neuropathology Department, Assistance Publique Des Hôpitaux de Marseille, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Regis J; Department of Functional and Stereotactic Neurosurgery and Radiosurgery, Timone University Hospital, Marseille, France.; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France.
Padovani L; Radiotherapy Department, Assistance Publique Des Hôpitaux de Marseille, Marseille, France. .; Neuropathology Department, Assistance Publique Des Hôpitaux de Marseille, Marseille, France. .; CRCM Inserm UMR1068, CNRS UMR7258 AMU UM105, Genome Instability and Carcinogenesis, Institut Paoli-Calmettes, Marseille, France. .; Radiotherapy Department, Assistance Publique des Hôpitaux de Marseille, marseille, France. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2022 Sep 26; Vol. 17 (1), pp. 160. Date of Electronic Publication: 2022 Sep 26.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/radiotherapy
Brain Neoplasms*/secondary
Brain Neoplasms*/surgery
Radiosurgery*/methods
Brain ; Humans ; Neoplasm Recurrence, Local/etiology ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies ; Salvage Therapy ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
Autorzy:: Appay R; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Bielle F; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuropathologie, Paris, France.
Sievers P; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Barets D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Fina F; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; ID Solutions, Research and Development, Grabels, France.
Boutonnat J; Service d'Anatomie et de Cytologie Pathologiques, CHU A Michallon, Grenoble, France.
Adam C; Assistance Publique - Hôpitaux de Paris Service de Neuropathologie, Groupe Hospitalier Universitaire Paris Sud, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Gauchotte G; Department of Pathology, Centre de Ressources Biologiques, CHRU, Nancy, France.; INSERM U1256, NGERE, Faculté de Médecine de Nancy, Université de Lorraine, Vandoeuvre-lès-Nancy, France.
Godfraind C; Neuropathology Unit, CHU Clermont-Ferrand and INSERM U1071, UCA, Clermont-Ferrand, France.
Lhermitte B; Département d'anatomie et de cytologie pathologiques, hôpitaux universitaires de Strasbourg, Strasbourg, France.
Maurage CA; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, Lille, France.
Meyronet D; Institut de Pathologie Est, groupe hospitalier Est, hospices civils de Lyon, Lyon, France.; Centre de recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR 5286, Cancer Cell Plasticity Department, Transcriptome Diversity in Stem Cells Laboratory, Université Claude-Bernard Lyon 1, Lyon, France.
Mokhtari K; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuropathologie, Paris, France.
Rousseau A; Département de Pathologie Cellulaire et Tissulaire, CHU Angers, Angers, France.; CRCINA Université de Nantes-Université d'Angers, Angers, France.
Tauziède-Espariat A; Department of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital, Paris, France.
Tortel MC; Service Anatomie Pathologique, Hôpitaux Civils de Colmar, Colmar, France.
Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Université Paul Sabatier, Toulouse III, Toulouse, France.
Burel-Vandenbos F; Laboratoire d'Anatomie et Cytologie Pathologiques, Hôpital Pasteur, CHU Nice, Nice, France.
Chotard G; Service de Pathologie, Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, France.
Pesce F; Institut de pathologie multi-sites, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Varlet P; Department of Neuropathology, GHU Paris-Psychiatrie Et Neurosciences, Sainte-Anne Hospital, Paris, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; Pokaż więcej
Źródło:: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Aug; Vol. 48 (5), pp. e12813. Date of Electronic Publication: 2022 Mar 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Central Nervous System Neoplasms*/genetics
Central Nervous System Neoplasms*/pathology
Glioma*/genetics
Glioma*/pathology
Neoplasms, Neuroepithelial*/genetics
Neoplasms, Neuroepithelial*/pathology
Receptor, Fibroblast Growth Factor, Type 1*/genetics
Class I Phosphatidylinositol 3-Kinases/genetics ; Class Ia Phosphatidylinositol 3-Kinase/genetics ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A2B5 Expression in Central Nervous System and Gliomas.
Autorzy:: Figarella-Branger D; Aix-Marseille University, CNRS, INP, Inst. Neurophysiopathol, 13005 Marseille, France.; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13005 Marseille, France.
Colin C; Aix-Marseille University, CNRS, INP, Inst. Neurophysiopathol, 13005 Marseille, France.
Baeza-Kallee N; Aix-Marseille University, CNRS, INP, Inst. Neurophysiopathol, 13005 Marseille, France.
Tchoghandjian A; Aix-Marseille University, CNRS, INP, Inst. Neurophysiopathol, 13005 Marseille, France.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Apr 23; Vol. 23 (9). Date of Electronic Publication: 2022 Apr 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Glioma*/metabolism
Animals ; Cell Differentiation ; Central Nervous System/metabolism ; Gangliosides/metabolism ; Neoplastic Stem Cells/metabolism ; Neuroglia/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Autorzy:: Métais A; AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Service d'Anatomie et Cytologie Pathologiques, CHU Pontchaillou, Rennes, France.
Appay R; AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Pagès M; GHU-Paris Sainte-Anne Hospital, Paris University, Paris, France.; Department of Genetics, Institut Curie, Paris, France.; SIREDO Paediatric Cancer Center, Institut Curie, Paris, France.; INSERM U830, Laboratory of Translational Research in Paediatric Oncology, Institut Curie, Paris, France.
Gallardo C; AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Silva K; Groupe Hospitalier Est, Département de Neuropathologie, Hospices Civils de Lyon, Bron, France.
Siegfried A; Department of Pathology, Toulouse University Hospital, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Université Paul Sabatier, Toulouse III, Toulouse, France.
Perbet R; Univ. Lille, Inserm, CHU Lille, Alzheimer and Tauopathies, Lille Neuroscience & Cognition, UMR-S1172, Lille, France.
Maurage CA; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, Lille, France.
Scavarda D; Aix-Marseille Univ, AP-HM, Institut de Neurosciences des Systèmes, CHU Timone, Service de Neurochirurgie infantile, Marseille, France.
Fina F; AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; ID Solutions, Research and Development, Grabels, France.
Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Université Paul Sabatier, Toulouse III, Toulouse, France.
Riffaud L; Department of Pediatric Neurosurgery, Rennes University Hospital, Rennes, France.; INSERM MediCIS, unit U1099 LTSI, Rennes 1 University, Rennes, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Figarella-Branger D; AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; Pokaż więcej
Corporate Authors:: contributors of the Biopathology RENOCLIP-LOC network
Źródło:: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Feb; Vol. 48 (2), pp. e12769. Date of Electronic Publication: 2021 Nov 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain/*pathology
Brain Neoplasms/*pathology
Epilepsy/*pathology
Neoplasms, Neuroepithelial/*pathology
Oligodendroglia/*pathology
Adolescent ; Adult ; Brain Neoplasms/complications ; Brain Neoplasms/genetics ; Child ; Child, Preschool ; DNA Methylation ; Epilepsy/etiology ; Epilepsy/genetics ; Female ; Humans ; Infant ; Male ; Neoplasms, Neuroepithelial/complications ; Neoplasms, Neuroepithelial/genetics ; Retrospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
Autorzy:: Jiguet-Jiglaire C; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France.
Boissonneau S; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; Department of Neursurgery, CHU Timone, Aix Marseille University, APHM, INSERM, MMG, Marseille, France.
Denicolai E; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Hein V; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Lasseur R; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Garcia J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Romain S; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Appay R; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France.
Graillon T; Department of Neursurgery, CHU Timone, Aix Marseille University, APHM, INSERM, MMG, Marseille, France.
Mason W; Princess Margaret Hospital, Toronto, Canada.
Carpentier AF; APHP, Paris University, Hopital Saint-Louis, Paris, France.
Brandes AA; Azienda AUSL- IRCCS-Istituto Scienze Neurologiche, Bologna, Italy.
Ouafik L'; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; APHM, CHU Nord, Service d'Onco-Biologie, Marseille, France.
Wick W; Heidelberg University Medical Center and German Cancer Research Center, Heidelberg, Germany.
Baaziz A; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Gigan JP; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Argüello RJ; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Figarella-Branger D; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France.
Chinot O; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; GlioME Team, APHM, CHU Timone, Service de Neuro-oncologie, Institut de Neurophysiopathologie (INP), CNRS 7051, 27 bd Jean Moulin, 13005, Marseille, France.
Tabouret E; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France. .; GlioME Team, APHM, CHU Timone, Service de Neuro-oncologie, Institut de Neurophysiopathologie (INP), CNRS 7051, 27 bd Jean Moulin, 13005, Marseille, France. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2022 Jan 03; Vol. 10 (1), pp. 1. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Angiogenesis Inhibitors/*therapeutic use
Bevacizumab/*therapeutic use
Brain Neoplasms/*drug therapy
Glioblastoma/*drug therapy
Matrix Metalloproteinase 9/*blood
Neutrophils/*metabolism
Adult ; Aged ; Angiogenesis Inhibitors/pharmacology ; Bevacizumab/pharmacology ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Female ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Humans ; Male ; Matrix Metalloproteinase 2/blood ; Middle Aged ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis.
Autorzy:: Pagano A; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Breuzard G; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Parat F; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Tchoghandjian A; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 8, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Figarella-Branger D; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 8, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.; Service d'Anatomie Pathologique et de Neuropathologie, CHU Timone, APHM, 13005 Marseille, France.
De Bessa TC; LIM 64: Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-090, SP, Brazil.
Garrouste F; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Douence A; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Barbier P; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
Kovacic H; Faculté des Sciences Médicales et Paramédicales, Institut de Neurophysiopathologie (INP), Team 9, UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Nov 19; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 19.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Somatotroph Tumors and the Epigenetic Status of the GNAS Locus.
Autorzy:: Romanet P; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.
Galluso J; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.
Kamenicky P; Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, 94270 Le Kremlin-Bicêtre, Île-de-France, France.
Hage M; Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, 94270 Le Kremlin-Bicêtre, Île-de-France, France.
Theodoropoulou M; Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig Maximilian University Munich, 80336 Munich, Germany.
Roche C; APHM, La Conception Hospital, Laboratory of Molecular Biology, 13385 Marseille, France.
Graillon T; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Timone Hospital Department of Neurosurgery, 13385 Marseille, France.
Etchevers HC; Aix Marseille Univ, INSERM, MMG, UMR1251, Marmara Institute, 13385 Marseille, France.
De Murat D; Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR8104, F-75014 Paris, France.
Mougel G; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.
Figarella-Branger D; Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13385 Marseille, France.
Dufour H; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Timone Hospital Department of Neurosurgery, 13385 Marseille, France.
Cuny T; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, Department of Endocrinology, Hospital La Conception, 13385 Marseille, France.
Assié G; Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR8104, F-75014 Paris, France.; Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France.
Barlier A; Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jul 15; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 15.
Typ publikacji:: Journal Article
MeSH Terms:: Chromogranins/*genetics
GTP-Binding Protein alpha Subunits, Gs/*genetics
Pituitary Neoplasms/*genetics
Somatotrophs/*metabolism
Adult ; Aged ; Aged, 80 and over ; Alleles ; Chromogranins/metabolism ; DNA Methylation ; Epigenesis, Genetic ; Female ; GTP-Binding Protein alpha Subunits, Gs/metabolism ; Gene Expression Regulation, Neoplastic ; Genomic Imprinting ; Humans ; Male ; Middle Aged ; Mutation ; Pituitary Neoplasms/metabolism ; Pituitary Neoplasms/pathology ; Somatotrophs/pathology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
Autorzy:: Pages M; GHU-Paris-Sainte-Anne Hospital, Paris University, 75014 Paris, France.
Uro-Coste E; Département de Pathologie, CHU Toulouse, 31000 Toulouse, France.; INSERM UMR 1037, Cancer Reaserch Center of Toulouse (CRCT), 31000 Toulouse, France.; Département d'Anatomie et Cytologie Pathologiques, Toulouse III University-Paul Sabatier, 31000 Toulouse, France.
Colin C; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, 13007 Marseille, France.
Meyronet D; Groupe Hospitalier Est, Département de Neuropathologie, Hospices Civils de Lyon, 69500 Bron, France.
Gauchotte G; Département de Pathologie, Hôpital Central, CHU, 54000 Nancy, France.
Maurage CA; Service Anatomie Pathologique, Pôle Pathologie Biologique, CHU Lille, 59000 Lille, France.
Rousseau A; Département de Pathologie Cellulaire et Tissulaire, CHU d'Angers, 49100 Angers, France.; CRCINA Université de Nantes-Université d'Angers, 49100 Angers, France.
Godfraind C; CHU Clermont-Ferrand, Service d'Anatomopathologie, 63003 Clermont-Ferrand, France.
Mokhtari K; Département de Neuropathologie Raymond Escourolle, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, 75013 Paris, France.
Silva K; Groupe Hospitalier Est, Département de Neuropathologie, Hospices Civils de Lyon, 69500 Bron, France.
Figarella-Branger D; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, 13007 Marseille, France.; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13005 Marseille, France.
Varlet P; GHU-Paris-Sainte-Anne Hospital, Paris University, 75014 Paris, France.
On Behalf Of The Renoclip-Loc Network; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Mar 18; Vol. 13 (6). Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: An AI-Powered Blood Test to Detect Cancer Using NanoDSF.
Autorzy:: Tsvetkov PO; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.; Faculté des Sciences Médicales et Paramédicales, Plateforme Interactome Timone, PINT, Aix Marseille Univ, 13009 Marseille, France.
Eyraud R; Laboratoire Hubert Curien UMR 5516, UJM-Saint-Etienne, CNRS, University Lyon, 42000 Saint Etienne, France.
Ayache S; CNRS, LIS, Aix-Marseille Univ, 13009 Marseille, France.
Bougaev AA; Oracle Labs, San Diego, CA 92121, USA.
Malesinski S; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.
Benazha H; CNRS, LIS, Aix-Marseille Univ, 13009 Marseille, France.
Gorokhova S; MMG, INSERM, Aix-Marseille Univ, 13009 Marseille, France.; Service de génétique Médicale, Hôpital de La Timone, APHM, 13005 Marseille, France.
Buffat C; Biochemistry and Endocrinology, Hôpital de la Conception, APHM, 13005 Marseille, France.; MEPHI, IRD, APHM, Aix-Marseille Univ, 13274 Marseille, France.
Dehais C; CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Université, Inserm, F-75006 Paris, France.; Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, F-75013 Paris, France.
Sanson M; CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Université, Inserm, F-75006 Paris, France.; Service de Neurologie 2-Mazarin, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, F-75013 Paris, France.
Bielle F; CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Université, Inserm, F-75006 Paris, France.; Département de Neuropathologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, F-75013 Paris, France.
Figarella Branger D; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.; Service d'Anatomie Pathologique et de Neuropathologie, CHU Timone, APHM, 13005 Marseille, France.
Chinot O; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.; Service de Neuro Oncologie, Hopital de La Timone, APHM, 13005 Marseille, France.
Tabouret E; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.; Service de Neuro Oncologie, Hopital de La Timone, APHM, 13005 Marseille, France.
Devred F; Faculté des Sciences Médicales et Paramédicales, Inst Neurophysiopathol, CNRS, INP, Aix Marseille Univ, 13005 Marseille, France.; Faculté des Sciences Médicales et Paramédicales, Plateforme Interactome Timone, PINT, Aix Marseille Univ, 13009 Marseille, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Mar 15; Vol. 13 (6). Date of Electronic Publication: 2021 Mar 15.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
Autorzy:: Burel-Vandenbos F; RENOCLIP-LOC PACA-CLARA, Central Laboratory of Pathology, University Hospital and Institute of Biology Valrose, Inserm U1091 - CNRS UMR7277, University Côte d'Azur, Nice, France.
Pierron G; Department of Genetics, Institut Curie, Paris, France.
Thomas C; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
Reynaud S; Department of Genetics, Institut Curie, Paris, France.
Gregoire V; Department of Biology-Pathology and Genetics, University Hospital, University of Lille, Lille, France.
Duhil de Benaze G; Department of Pediatric Oncology, University Hospital, University Côte d'Azur, Nice, France.
Croze S; Plateforme ProfileXpert 'Génomique & Microgénomique', SFR Santé Lyon Est, UMS 3453 CNRS/US 7 INSERM, Lyon, France.
Chivoret N; Department of Neurosurgery, University Hospital, University Côte d'Azur, Nice, France.
Honavar M; Department of Pathology, Hospital Pedro Hispano, Matosinhos, Portugal.
Figarella-Branger D; Department of Pathological Anatomy and Neuropathology, Timone Hospital, Public Assistance-Marseille Hospitals (APHM), Marseille, France.
Maurage CA; Department of Biology-Pathology and Genetics, University Hospital, University of Lille, Lille, France.
Pedeutour F; Laboratory of Solid Tumors Genetics, University Hospital, University Côte d'Azur, Nice, France.
Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
Godfraind C; RENOCLIP-LOC PACA-CLARA, Laboratory of Pathology, University Hospital of Clermont-Ferrand and University Clermont-Auvergne, M2iSH UMR1071, Clermont-Ferrand, France.; Pokaż więcej
Źródło:: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2020 Aug; Vol. 46 (5), pp. 506-509. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji:: Case Reports; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms/*genetics
Kruppel-Like Transcription Factors/*genetics
Neoplasms, Neuroepithelial/*genetics
Repressor Proteins/*genetics
Trans-Activators/*genetics
Tumor Suppressor Proteins/*genetics
Brain Neoplasms/pathology ; Female ; Humans ; Infant ; Neoplasms, Neuroepithelial/pathology ; Oncogene Fusion/genetics

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.
Autorzy:: Deng MY; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Junior Research Group Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Sturm D; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Junior Research Group Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.
Stichel D; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Witt H; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.
Ecker J; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Wittmann A; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Junior Research Group Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schittenhelm J; Department of Neuropathology, Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital of Tübingen, Tübingen, Germany.
Ebinger M; Department of Pediatric Hematology/Oncology, Children's University Hospital, Tübingen, Germany.
Schuhmann MU; Department of Neurosurgery, Division of Pediatric Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
Figarella-Branger D; Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Aix Marseille Univ, APHM, CNRS, INP, Marseille, France.
Aronica E; Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Staszewski O; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Preusser M; Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Haberler C; Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria.
Lauten M; Department of Paediatrics, Paediatric Haematology and Oncology, University of Lübeck, Lübeck, Germany.
Schüller U; Department of Paediatric Haematology and Oncology and Institute of Neuropathology, University Medical Centre Hamburg-Eppendorf, Research Institute at the Children's Cancer Centre Hamburg, Hamburg, Germany.
Hartmann C; Department of Neuropathology, Institute of Pathology, Hannover Medical School (MHH), Hannover, Germany.
Snuderl M; Department of Pathology, Division of Neuropathology, NYUSoM, New York, NY, USA.
Dunham C; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Jabado N; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Department of Pediatrics, McGill University, McGill University Heath Centre Research Institute, Montreal, QC, Canada.
Wesseling P; Department of Pathology, Amsterdam Universities Medical Centers/VUmc, Brain Tumor Center Amsterdam University Medical Center, Amsterdam, The.; Princess Máxima Center for Pediatric Oncology, Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
Deckert M; Institute of Neuropathology, University Hospital of Cologne, Cologne, Germany.
Keyvani K; Institute of Neuropathology, University of Duisburg-Essen, Essen, Germany.
Gottardo N; Telethon Kids Institute, Perth, WA, Australia.; Centre for Child Health Research, University of Western Australia, Perth, WA, Australia.; Department of Oncology, Princess Margaret Hospital, Perth, WA, Australia.
Giangaspero F; Department of Radiological, Oncological and Anatomo-Pathological Science, Sapienza University of Rome, Rome, Italy.; IRCCS Neuromed, Pozzilli (Is), Italy.
von Hoff K; Department of Paediatric Haematology and Oncology, Charité-Universitätsmedizin, Berlin, Germany.
Ellison DW; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Pietsch T; Institute of Neuropathology, Brain Tumor Reference Center of the Society for Neuropathology and Neuroanatomy, University of Bonn Medical Center, Bonn, Germany.
Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.
Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Kool M; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Korshunov A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wick W; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
von Deimling A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Hopp Children's Cancer Center (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.
Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Junior Research Group Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sahm F; Hopp Children's Cancer Center Heidelberg (KiTZ), University Hospital Heidelberg, Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pokaż więcej
Źródło:: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2020 Aug; Vol. 46 (5), pp. 422-430. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Central Nervous System Neoplasms/*genetics
Central Nervous System Neoplasms/*pathology
Chromosomes, Human, Pair 14/*genetics
Glioma/*genetics
Glioma/*pathology
DNA Methylation ; Female ; Humans ; Male ; Monosomy ; Neurocytoma/genetics ; Neurocytoma/pathology ; Oligodendroglioma/genetics ; Oligodendroglioma/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases.
Autorzy:: Appay R; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Pages M; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Neuropathologie, GHU Paris - Hôpital Sainte-Anne, Paris, France.; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120, Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Varlet P; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.; Service de Neuropathologie, GHU Paris - Hôpital Sainte-Anne, Paris, France.; INSERM UMR 1266, IMA-Brain, Institut de Psychiatrie et de Neurosciences de Paris, Paris, France.
Figarella-Branger D; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France. dominiquefrance.figarella@ap-hm.fr.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France. dominiquefrance.figarella@ap-hm.fr.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2020 Jun 30; Vol. 8 (1), pp. 95. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain Neoplasms/*pathology
Meningeal Neoplasms/*pathology
Oligodendroglioma/*pathology
Adult ; Brain Neoplasms/genetics ; Chromosome Deletion ; Chromosomes, Human, Pair 1/genetics ; Chromosomes, Human, Pair 19/genetics ; Class I Phosphatidylinositol 3-Kinases/genetics ; Female ; Humans ; Meningeal Neoplasms/genetics ; Mutation ; Oligodendroglioma/genetics ; Proto-Oncogene Proteins B-raf/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database.
Autorzy:: Clavreul A; Département de Neurochirurgie, CHU, 4 rue Larrey, 49 933, Angers Cedex 9, France.; CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Soulard G; Département de Neurochirurgie, CHU, 4 rue Larrey, 49 933, Angers Cedex 9, France.; CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Lemée JM; Département de Neurochirurgie, CHU, 4 rue Larrey, 49 933, Angers Cedex 9, France.; CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
Rigot M; Département Promotion, Direction de la Recherche, CHU Nantes, Nantes, France.
Fabbro-Peray P; Département de Biostatistique, Epidémiologie, Santé Publique, CHU Nîmes, Nîmes, France.; Unité de recherche EA2415, Université de Montpellier, Montpellier, France.
Bauchet L; Département de Neurochirurgie, Hôpital Gui de Chauliac, CHU Montpellier, Université de Montpellier, Montpellier, France.; Institut des Neurosciences de Montpellier INSERM U1051, Montpellier, France.
Figarella-Branger D; APHM, Hôpital de la Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Menei P; Département de Neurochirurgie, CHU, 4 rue Larrey, 49 933, Angers Cedex 9, France. .; CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France. .; Pokaż więcej
Corporate Authors:: FGB network
Źródło:: Journal of translational medicine [J Transl Med] 2020 Apr 30; Vol. 18 (1), pp. 181. Date of Electronic Publication: 2020 Apr 30.
Typ publikacji:: Journal Article; Published Erratum

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Figarella-Branger, D."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język